Allworth Financial LP Viridian Therapeutics, Inc.\De Transaction History
Allworth Financial LP
- $17.4 Billion
- Q1 2025
A detailed history of Allworth Financial LP transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Allworth Financial LP holds 33 shares of VRDN stock, worth $425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33Holding current value
$425% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
200Shares Held
79.6MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$61.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$59.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$58.3 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$50.1 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$45.4 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $515M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...